Cost-Effectiveness Analysis of the South African Infant National Immunization Program for the Prevention of Pneumococcal Disease

被引：0
|
作者：
Liping Huang
Cheryl L. McDade
Johnna E. Perdrizet
Michele R. Wilson
Sophie A. Warren
Susan Nzenze
Renilla Sewdas
机构：
[1] Pfizer Inc.,School of Public Health
[2] RTI Health Solutions,undefined
[3] University of the Witwatersrand,undefined
[4] ZAF,undefined
[5] Health and Value,undefined
[6] Pfizer Laboratories (Pty) Ltd,undefined
[7] ZAF,undefined
来源：
Infectious Diseases and Therapy | 2023年 / 12卷
关键词：
PCV; PCV13; PCV20; Pneumococcal disease; Vaccine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：933 / 950
页数：17
相关论文
共 50 条
  • [1] Cost-Effectiveness Analysis of the South African Infant National Immunization Program for the Prevention of Pneumococcal Disease
    Huang, Liping
    McDade, Cheryl L.
    Perdrizet, Johnna E.
    Wilson, Michele R.
    Warren, Sophie A.
    Nzenze, Susan
    Sewdas, Renilla
    INFECTIOUS DISEASES AND THERAPY, 2023, 12 (03) : 933 - 950
  • [2] Estimating the cost-effectiveness of an infant 13-valent pneumococcal conjugate vaccine national immunization program in China
    Shen, Kunling
    Wasserman, Matthew
    Liu, Dongdong
    Yang, Yong-Hong
    Yang, Junfeng
    Guzauskas, Greg F.
    Wang, Bruce C. M.
    Hilton, Betsy
    Farkouh, Raymond
    PLOS ONE, 2018, 13 (07):
  • [3] COST-EFFECTIVENESS OF QUADRIVALENT INFLUENZA VACCINE FOR NATIONAL IMMUNIZATION PROGRAM IN SOUTH KOREA
    Shin, G.
    Choi, S.
    Lim, J.
    Kang, D.
    Bae, E.
    Choi, M. J.
    NhoJy
    Song, J. Y.
    Cheong, H. J.
    Yun, J. W.
    Kim, Y.
    Lim, E.
    VALUE IN HEALTH, 2017, 20 (09) : A789 - A789
  • [4] COST-EFFECTIVENESS OF PNEUMOCOCCAL VACCINATION IMPLEMENTATION IN OLDER ADULT IMMUNIZATION SCHEDULE IN THE BRAZILIAN NATIONAL PROGRAM
    Parellada, C.
    Riveros, B. S.
    Moreira, T. N. F.
    Deb, A.
    Owusu-Edusei, K.
    Yande, S.
    Chitale, R.
    Johnson, K. D.
    VALUE IN HEALTH, 2022, 25 (07) : S375 - S375
  • [5] A Cost-Effectiveness Analysis of a Proposed National Falls Prevention Program
    Wu, Shinyi
    Keeler, Emmett B.
    Rubenstein, Laurence Z.
    Maglione, Margaret A.
    Shekelle, Paul G.
    CLINICS IN GERIATRIC MEDICINE, 2010, 26 (04) : 751 - +
  • [6] Cost-effectiveness analysis of the introduction of the pneumococcal conjugate vaccine (PCV-13) in the Egyptian national immunization program, 2013
    Sibak, Mohammed
    Moussa, Ibrahim
    El-Tantawy, Nasr
    Badr, Shaza
    Chaudhri, Irtaza
    Allam, Essam
    Baxter, Louise
    Freikha, Saiyed Abo
    Hoestlandt, Celine
    Lara, Carlos
    Hajjeh, Rana
    Munier, Aline
    VACCINE, 2015, 33 : A182 - A191
  • [7] Retrospective Impact Analysis and Cost-Effectiveness of the Pneumococcal Conjugate Vaccine Infant Program in Australia
    Johnna Perdrizet
    Yuen S. Lai
    Scott Williams
    Valda A. Struwig
    Matt Wasserman
    Infectious Diseases and Therapy, 2021, 10 : 507 - 520
  • [8] Retrospective Impact Analysis and Cost-Effectiveness of the Pneumococcal Conjugate Vaccine Infant Program in Australia
    Perdrizet, Johnna
    Lai, Yuen S.
    Williams, Scott
    Struwig, Valda A.
    Wasserman, Matt
    INFECTIOUS DISEASES AND THERAPY, 2021, 10 (01) : 507 - 520
  • [9] Cost-effectiveness Analysis of the National Perinatal Hepatitis B Prevention Program
    Barbosa, Carolina
    Smith, Emily A.
    Hoerger, Thomas J.
    Fenlon, Nancy
    Schillie, Sarah F.
    Bradley, Christina
    Murphy, Trudy V.
    PEDIATRICS, 2014, 133 (02) : 243 - 253
  • [10] Cost-effectiveness of a national immunization program with the 13-valent pneumococcal conjugate vaccine compared with the 10-valent pneumococcal conjugate vaccine in South Korea
    Kim, Hye-Young
    Park, Seong-Beom
    Kang, Eun-Sil
    Lee, Sang-Min
    Kim, Hyun-Jin
    Wasserman, Matt
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (03) : 909 - 918
12345